Edelson P Kaitlyn, James Kaitlyn E, Leong Aaron, Arenas Juliana, Cayford Melody, Callahan Michael J, Bernstein Sarah N, Tangren Jessica Sheehan, Hivert Marie-France, Higgins John M, Nathan David M, Powe Camille E
Division of Maternal Fetal Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts.
J Clin Endocrinol Metab. 2020 May 1;105(5):e1999-2007. doi: 10.1210/clinem/dgaa053.
To characterize the relationship between hemoglobin A1c (HbA1c) levels and glucose tolerance across pregnancy and postpartum.
In a longitudinal study of pregnant women with gestational diabetes risk factors (N = 102), we performed oral glucose tolerance testing (OGTT) and HbA1c measurements at 10-15 weeks of gestation, 24-30 weeks of gestation (N = 73), and 6-24 weeks postpartum (N = 42). Complete blood counts were obtained from clinical records. We calculated HbA1c-estimated average glucose levels and compared them with mean OGTT glucose levels (average of fasting, 1- and 2-hour glucose levels). Linear mixed effects models were used to test for longitudinal changes in measurements.
Mean OGTT glucose increased between 10-15 and 24-30 weeks of gestation (β = 8.1 mg/dL, P = .001), while HbA1c decreased during the same time period (β = -0.13%, P < .001). At 10-15 weeks of gestation and postpartum the discrepancy between mean OGTT glucose and HbA1c-estimated average glucose was minimal (mean [standard deviation]: 1.2 [20.5] mg/dL and 0.16 [18.1] mg/dL). At 24-30 weeks of gestation, the discrepancy widened (13.2 [17.9] mg/dL, β = 12.7 mg/dL, P < .001, compared to 10-15 weeks of gestation, with mean OGTT glucose being higher than HbA1c-estimated average glucose). Lower hemoglobin at 24-30 weeks of gestation was associated with a greater discrepancy (β = 6.4 mg/dL per 1 g/dL lower hemoglobin, P = .03 in an age- and gestational age-adjusted linear regression model).
HbA1c accurately reflects glycemia in the 1st trimester, but underestimates glucose intolerance in the late 2nd trimester. Lower hemoglobin level is associated with greater underestimation. Accounting for gestational age and maternal hemoglobin may improve the clinical interpretation of HbA1c levels during pregnancy.
描述妊娠期间及产后糖化血红蛋白(HbA1c)水平与糖耐量之间的关系。
在一项针对有妊娠期糖尿病风险因素的孕妇的纵向研究中(N = 102),我们在妊娠10 - 15周、妊娠24 - 30周(N = 73)以及产后6 - 24周(N = 42)进行了口服葡萄糖耐量试验(OGTT)和HbA1c测量。从临床记录中获取全血细胞计数。我们计算了HbA1c估算的平均血糖水平,并将其与OGTT平均血糖水平(空腹、1小时和2小时血糖水平的平均值)进行比较。使用线性混合效应模型来检验测量值的纵向变化。
妊娠10 - 15周与24 - 30周之间,OGTT平均血糖升高(β = 8.1 mg/dL,P = 0.001),而同期HbA1c下降(β = -0.13%,P < 0.001)。在妊娠10 - 15周和产后,OGTT平均血糖与HbA1c估算的平均血糖之间的差异最小(均值[标准差]:1.2 [20.5] mg/dL和0.16 [18.1] mg/dL)。在妊娠24 - 30周时,差异扩大(13.2 [17.9] mg/dL,β = 12.7 mg/dL,P < 0.001,与妊娠10 - 15周相比,OGTT平均血糖高于HbA1c估算的平均血糖)。妊娠24 - 30周时血红蛋白水平较低与更大的差异相关(在年龄和孕周调整的线性回归模型中,每降低1 g/dL血红蛋白,β = 6.4 mg/dL,P = 0.03)。
HbA1c在孕早期能准确反映血糖情况,但在孕晚期会低估葡萄糖不耐受情况。较低的血红蛋白水平与更大程度的低估相关。考虑孕周和孕妇血红蛋白水平可能会改善孕期HbA1c水平的临床解读。